Mitosis-Mediated Intravasation in a Tissue-Engineered Tumor-Microvessel Platform.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28923855.
- Also identified by DOI 10.1158/0008-5472.CAN-16-3279 and PMC identifier 5690825.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intravasation involves the migration of tumor cells across the local endothelium and escape into vessel flow. Although tumor cell invasiveness has been correlated to increased intravasation, the details of transendothelial migration and detachment into circulation are still unclear. Here, we analyzed the intravasation of invasive human breast cancer cells within a tissue-engineered microvessel model of the tumor microenvironment. Using live-cell fluorescence microscopy, we captured 2,330 hours of tumor cell interactions with functional microvessels and provide evidence for a mitosis-mediated mechanism where tumor cells located along the vessel periphery are able to disrupt the vessel endothelium through cell division and detach into circulation. This model provides a framework for understanding the physical and biological parameters of the tumor microenvironment that mediate intravasation of tumor cells across an intact endothelium. <i>Cancer Res; 77(22); 6453-61. ©2017 AACR</i>.
Medical subject headings
- Microvessels
- Mitosis
- Neoplasms